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AIM: To describe the case profile of maternal death resulting from hypertensive disorders in pregnancy and to propose measures for
its reduction.
METHODS: The Committee on Maternal Mortality of São Paulo City has identified 609 cases of obstetric maternal death between
1995 and 1999 with an underreporting rate of 52.2% and a maternal mortality rate of 56.7/100,000 live births. Arterial hypertension
was the main cause of maternal death, corresponding to 142 (23.3%) cases.
RESULTS: Ninety-five (66.9%) of the deaths occurred during the puerperal period and 34 (23.9%) occurred during pregnancy. The
time of death was not reported in 13 (9.2%) cases. Seizures were observed in 41 cases and magnesium sulfate was used in four of
them. The causes of death were ruled to be cerebrovascular accident (44.4%), acute pulmonary edema (24.6%), and coagulopathies
(14.1%). Cesarean section was performed in 85 (59.9%) cases and vaginal delivery in 15 (16.0%).
CONCLUSION: Complications of arterial hypertension are responsible for the high rates of pregnancy-related maternal death in
São Paulo City. Quality prenatal care and appropriate monitoring of the hypertensive pregnant patient during and after delivery are
important measures for better control of this condition and are essential to reduce disorders in pregnancy.
KEYWORDS: Maternal mortality. Arterial hypertension. Risk pregnancy. Chronic arterial hypertension. Preeclampsia/eclampsia.
Magnesium sulfate.
INTRODUCTION
Over the last decade, the study of maternal mortality has
become of the utmost importance in the evaluation of the
quality of healthcare offered to a population.1 Developed
countries, which present very low maternal mortality rates
(MMR), use this indicator merely for comparative purposes
and self-evaluation. However, developing countries with
rates higher than 50 maternal deaths/100,000 live births,
as is the case for Brazil, should not only quantify, but also
study maternal deaths on a case-by-case basis in an attempt
to identify deficiencies in care and to establish appropriate
measures to reduce these deaths.
Prenatal care is fundamental for the reduction of ma-
ternal death.2 Primary care programs that were able to re-
duce maternal mortality are characterized by structure and
coherence, access to adequate medications and materials,
detailed therapeutic guidance, and differentiated follow-up.3
The profile of diseases that lead to the death of a preg-
nant woman or puerpera varies according to the degree and
type of difficulty encountered by the communities, with dif-
ferences from country to country or even within the same
country.4,5 In most developing countries, arterial hyperten-
sion is the main cause of maternal death.6
A high frequency of maternal death resulting from hy-
pertension disorders in pregnancy has been reported in the
city of São Paulo1 and throughout Brazil.4 Moreover, ec-
lampsia has been indicated as a possible aggravating fac-
tor of hypertension. The objective of the present study was
to evaluate the profile of these women and to identify pos-
sible deficiencies in care that might have contributed to or
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worsened this clinical condition resulting in maternal death,
as well as to propose interventions to reduce the incidence
of maternal death.
MATERIAL AND METHODS
The data used in the present study were requested from
the Committee on Maternal Mortality of São Paulo City
(CMMMSP), of which the first author is a member. A ret-
rospective ecological study was conducted comprising ma-
ternal deaths with a history of hypertensive disorders in
pregnancy [preeclampsia/eclampsia (PE/E) and chronic hy-
pertension (CH)] identified between 1995 and 1999 in São
Paulo City.
The size and complexity of the city of São Paulo does
not permit us to completely investigate all the deaths of
women of fertile age (10 to 49 years), therefore the
CMMMSP used the “mask method” for the selection of
known positive or presumed cases of maternal death. This
method has been used successfully since 19931. The mask
method consists of reading the death certificate in order to
identify any information in the text that indicates the pres-
ence of pregnancy-related events, i.e., events that occurred
during or within one year after pregnancy. Any death cer-
tificate reporting a disease or disorder that may worsen or
interfere with the physiological progression of pregnancy
or puerperium, such as cerebrovascular accident, cardiovas-
cular descompensation, events related to arterial hyperten-
sion, general infections, and manifestations of acute anemia
and its disorders in pregnancy, was also added. After ap-
propriate selection of confirmed or suspected cases of ma-
ternal death, a standard questionnaire recommended by the
Ministry of Health7 was applied, which compiles data col-
lected during home and hospital visits. When a positive case
of maternal death was identified, the case was then codi-
fied according to the ICD-10 which was based on the in-
formation obtained and subsequently classified.
The CMMMSP defines reported maternal deaths as any
case in which simple analysis of the death certificate con-
firms, beyond any doubt, the presence of pregnancy-related
events. Underreported maternal death was defined as an
event identified during the investigation of the case with
no information being present in the death certificate. At the
end of the investigation process and classification of posi-
tive events, the rate of underreporting was calculated by di-
viding the number of underreported maternal deaths by the
number of declared maternal deaths.
The investigation charts of the 142 cases of maternal
deaths due to hypertensive disorders in pregnancy were
analyzed by the authors in order to identify social charac-
teristics, age, obstetric history, prenatal care, hospital care
(medications, obstetric management, and resulting disor-
ders in pregnancy), newborn survival, and place and time
of maternal death during pregnancy and puerperium.
The present study was conducted according to the ethi-
cal guidelines established by the Declaration of Helsinki
and according to the norms outlined by the World Medi-
cal Association.
RESULTS
During the period from 1995 to 1999, a total of 1,073,917
live births and 609 confirmed cases of maternal death were
reported in the city of São Paulo, which corresponds to a
MMR of 56.7/100,000 live births during the period. The pres-
ence of maternal death was omitted in 209 of these death
certificates, resulting in an underreporting rate of 52.2%.
The main cause of maternal death found in the present
study was arterial hypertension (Table 1) in 142 (23.3%)
cases, hemorrhagic disorders in pregnancy during the 2nd-
3rd trimester and puerperal period in 105 (17.2%), and abor-
tions in 66 (10.8%). Among the 142 (23.3%) maternal deaths
due to hypertensive disorders in pregnancy, 139 occurred up
to puerperal day 42 and three occurred between puerperal
day 43 and one year after delivery or abortion (extended pu-
erperium), resulting in a specific MMR due to arterial hy-
pertension of 13.2/100,000 live births. PE/E was the lead-
ing cause of death in 99 cases and 43 were due to chronic
hypertension disorders in pregnancy. Figure 1 shows the dis-
tribution of 142 cases of maternal death resulting from
chronic hypertension disorders in pregnancy and PE/E and
the respective MMRs calculated according to age.
Seventy-four (52.1%) of the women were single, 57
(40.1%) were married, six (4.2%) were co-habiting, four
(2.8%) were widows, and one case (0.7%) where the mari-
tal status was unknown. On the basis of the 103 (72.5%)
death certificates reporting ethnic origin/race, 65 (63.1%)
women were white, 27 (26.2%) were mulatto, 10 (9.7%)
were black, and one (1.0%) was of Asian origin.
Table 1 - Distribution of the 609 cases of maternal death
according to the main causes of death (São Paulo City, 1995-
1999)
Cause of death N %
Arterial hypertension 142 23.3
Hemorrhagic disorders 105 17.2
Abortion 66 10.8
Cardiovascular diseases 58 9.5
Puerperal infection 43 7.1
Others 195 32.0
TOTAL 609 100.0
Source: CMMMSP.
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Data regarding parity were investigated in 96 (67.6%)
cases. Cases of PE/E included 33 (48.5%) primigravidae,
14 (20.6%) secundigravidae, 13 (19.1%) tertigravidae, and
eight (11.8%) multigravidae. Whereas cases of chronic
hypertension included five (17.9%) primigravidae, four
(14.3%) secundigravidae, seven (25.0%) tertigravidae, and
12 (42.9%) multigravidae.
Data regarding prenatal care were obtained in 56
(39.4%) cases, with 37 (66.1%) of the women receiving pre-
natal care, whereas 19 (33.9%) did not. The reasons for fail-
ure in seeking prenatal follow-up were identified based on
the data collected during home visits and included attempts
to hide the pregnancy and lack of care concerning the pa-
tient’s own well-being.
The time of death during pregnancy and puerperium is
shown in Table 2.
Delivery was performed in 100 (70.4%) cases, includ-
ing 85 (85.0%) cesarean sections and 15 (15.0%) vaginal
deliveries. Post-mortem cesarean section was performed in
six cases, with successful recovery of the neonate in two
(33.3%). Time was not sufficient for any intervention in
28 (19.7%) cases and information regarding the type of pro-
cedure was unavailable in 14 (9.9%) cases,
The pregnancy disorders that resulted in the death of
142 patients are shown in Table 3. The most frequent cause
was cerebrovascular accident (45.1%), acute pulmonary
edema (27.5%), and coagulopathies (16.2%), with the
HELLP syndrome being responsible for 12 (52.2%) deaths.
In 17 (12.0%) cases, the pregnant woman or puerpera was
admitted to the hospital with cardiorespiratory arrest. Eleven
(64.7%) of these patients had chronic hypertension and six
(35.3%) presented with pregnancy disorders of PE/E, of which
13 (76.5%) were gravidae and four (23.5%) were puerperae.
Eleven (64.7%) patients were older than 30 years and five
(83.3%) of the six post-mortem cesarean sections were per-
formed in this group. Puerperae died on average 11 days after
delivery, with a mean of 9 days for patients with PE/E and a
mean of 20 days for chronic hypertensive patients.
The maternal death was explicitly stated in the death
certificate of 82 cases among the 99 cases of PE/E,
(underreporting rate of 20.7%) and of 26 patients among
the 43 with chronic hypertension (underreporting rate of
65.4%). The overall underreporting rate among the 142
cases was 31.5%. The fields on the death certificate inquir-
ing about the presence of pregnancy or puerperium were
correctly filled out in 28 (19.7%) cases.
With respect to the place of death, 139 (97.9%) women
died at the hospital and three (2.1%) died at home. Public
hospitals attended to 112 (80.6%) cases and private hospi-
tals attended to 22 (15.8%). Five (3.6%) patients died at
hospitals outside São Paulo City. Among the 95 (73.6%)
puerperae, 74 (77.9%) died at the same hospital where they
gave birth either during the immediate postpartum period
or days later when returning to the hospital.
Eleven (7.7%) patients were transferred to referral hos-
pitals, nine (81.8%) of them after delivery and two (18.2%)
during pregnancy. Most of the institutions receiving the
cases were tertiary hospitals.
Figure 1 - Percent distribution and the respective maternal mortality rate
(MMR) of cases of maternal death resulting from disorders in pregnancy of
preeclampsia/eclampsia (PE/E) and chronic hypertension (CH) according to
age of the pregnant women or puerpera at the time of death (São Paulo City,
1995-1999).
Table 3 - Distribution of the 142 cases of obstetric maternal
death resulting from hypertensive disorders in pregnancy
according to the determining cause of death (São Paulo City,
1995-1999)
Cause of death N %
Cerebrovascular accident 64 45.1
Acute pulmonary edema 39 27.5
Coagulopathies 23 16.2
Acute myocardial infarction 5 3.5
Others 10 7.0
Unknown 1 0.7
TOTAL 142 100.0
Source: CMMMSP.
Table 2 - Distribution of the 99 cases of maternal death due
to preeclampsia/eclampsia (PE/E) and of the 43 cases
resulting from disorders in pregnancy of chronic hyper-
tension (CH) according to time of death during pregnancy
and puerperium (São Paulo City, 1995-1999)
Pregnancy period PE/E CH Total %
N % N %
First trimester 0 0.0 0 0.0 0 0.0
Second trimester 3 3.0 11 25.6 14 9.9
Third trimester 7 7.1 13 30.2 20 14.1
Puerperium 76 76.8 19 44.2 95 66.9
Unknown 13 13.1 0 0.0 13 9.2
TOTAL 99 100.0 43 100.0 142 100.0
Source: CMMMSP.
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Eclampsia, i.e., the presence of seizures, was identified
in 41 (28.9%) cases, with four (9.8%) of them using mag-
nesium sulfate. However, analysis of the 142 records re-
vealed the use of magnesium sulfate in 10 (7.0%) cases,
including nine (90.0%) with PE/E and one (10.0%) with
chronic hypertension. Other drugs used for the treatment
of seizures and for the control of hypertensive peaks were
benzodiazepines, phenobarbital, pindolol, hydralazine, al-
pha-methyldopa, sodium nitroprussiate, propranolol,
nifedipine, and diuretics.
Information regarding the health condition of the
newborns was available in 96 (66.2%) cases, including 58
(61.7%) newborns who had died and 36 (38.3%) who sur-
vived. Among the 85 (59.9%) women that under went a
cesarean section (including the six post mortem cesarean sec-
tions), neonatal death was reported in 22 (25.9%) cases and
31 (36.5%) newborns were alive. No information about the
conceptus was available in the remaining 32 (37.6%) cases.
DISCUSSION
The study of trends in maternal death is of great im-
portance, both for the evaluation of a community health sys-
tem and for the elaboration of concrete proposals to reduce
this event. Compared to most developed countries and their
cities, São Paulo City has a much higher MMR8 with an
underreporting rate of 52.2%, which is within the range
observed in Europe and in the United States.9
Hypertensive disorders in pregnancy, delivery, and pu-
erperium represented the main cause of maternal death in
São Paulo City, resulting in 23.3% of deaths. In contrast,
arterial hypertension occupies third place (15.9%) after
thromboembolism (19.9%) and hemorrhage (18.2%) in the
United States.10
Arterial hypertension can affect the pregnant woman in
various manners11 which, if not controlled adequately, may
pose a risk to the mother and conceptus. Unfortunately, our
study is based on the analysis of medical records and of data
present in the death certificate, a fact that may lead to er-
rors in the correct classification of the type of arterial hy-
pertension. Aggravation of the clinical manifestations
through association with preeclampsia (preeclampsia super-
imposed upon chronic hypertension), which leads to con-
vulsions, is observed in many chronic hypertensive women.
One of the criteria used for the classification of groups is
based on the presence of myocardial hypertrophy, which is
generally absent in cases of pure preeclampsia, a fact that
does not exclude the presence of mixed manifestations.
Similarly, primigravidae with chronic hypertension with-
out previous follow-up may present hypertensive peaks that
lead the physician to the diagnosis of pure preeclampsia.
Although the prenatal care structure of São Paulo City
provides ample coverage, 33.9% of patients for whom data
were available did not receive prenatal care.
The fact that most maternal deaths due to arterial hyper-
tension occurred in the public sector (80.6% of the cases se-
lected), the presence of pregnancy within an unstable mari-
tal situation (52.1% of the patients were single) and the lack
of prenatal care in 33.9% of cases, suggested that the group
of women were of low socioeconomic standing. In contrast
to the United States,10 the present study showed that mater-
nal death due to hypertensive disorders in pregnancy mainly
affected white women (63.1%), reflecting the different nu-
ances of this disorder between population groups.
With respect to age (Figure 1), maternal mortality due
to PE/E affected younger women (58.6% of women up to
29 years of age), whereas maternal death resulting from
chronic hypertension was frequent in older multiparous
pregnant women or puerperae (65.1% of women aged 30
to 49 years), in agreement with the literature.11
As shown in Table 2, most deaths occurred during the
puerperal period (66.9%), which is in accordance with a
worldwide trend.12 However, comparisons between deaths
due to PE/E and disorders in pregnancy of chronic hyper-
tension showed that 55.8% of chronic hypertensive patients
died during pregnancy, in contrast to those who developed
PE/E (10.1%). This finding might be explained by the fact
that pregnant women with PE/E are healthier when they
develop hypertension compared to chronic hypertensive pa-
tients who already present variable degrees of organic and/
or functional lesions of the cardiocirculatory and renal sys-
tems even before becoming pregnant.13
Multiparity is generally accompanied by a certain amount
of carelessness on the part of both the patient and the attend-
ing physician because there are symptoms and situations that
may pose a health risk that are often neglected. However,
hypertensive pregnant women should be guided and prepared
for pregnancy and its manifestations, which, although physi-
ological, impose an overload on the maternal organism. In
this respect, hypertensive women should be rigorously moni-
tored in order to ensure a safer pregnancy. The underlying
disease should be treated adequately before the beginning of
pregnancy to stabilize the pre-existing hypertensive condi-
tion so that women will be healthier when they become preg-
nant.14 The introduction of anti-hypertensive medication
(methyldopa, beta-blockers, and calcium channel antagonists)
improves maternal-fetal prognosis, prevents hypertension-
induced organic deterioration, reduces the incidence of dis-
seminated intravascular coagulation, pulmonary edema, he-
patic and renal failure, protects the mother against hyper-
or hypotensive episodes during anesthesia, guarantees a
healthy uterine-placental blood flow, prolongs the duration
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of gestation, and reduces the length of hospitalization.15
As shown in Table 3, the three main determining causes
of maternal death due to arterial hypertension were neuro-
logical disorders in pregnancy (54.1%), acute pulmonary
edema (27.5%), and hemorrhagic events, especially HELLP
syndrome (16.2%). Neurological disorders in pregnancy
(cerebrovascular accident) have been attributed to difficul-
ties in the control and reduction of arterial hypertension.16
Hydralazine, one of the best drugs for the control of hyper-
tensive episodes,17 provides adequate reduction of the hy-
pertensive peak, minimizing the risks of intracranial bleed-
ing and hypertensive encephalopathy.
In the case of imminent eclampsia or eclampsia, mag-
nesium sulfate should be adequately administered in order
to minimize the morbidity and mortality associated with dis-
orders in pregnancy resulting from convulsive episodes.18 In
the present study, this medication was only used in 7.0% of
all cases and in 10% of cases with a record of the occurrence
of seizures. Magnesium sulfate is certainly the best currently
available anti-convulsant drug whose efficacy has been con-
firmed over a century of uninterrupted use. However, 43%
of hospitals in the State of São Paulo do not possess the ba-
sic emergency care kit containing this drug.19 Thus, it is es-
sential that emergency care services have access to low cost
drugs with proven efficacy, such as magnesium sulfate and
hydralazine, whose adequate administration can reduce the
disorders in pregnancy of arterial hypertension.
With respect to acute pulmonary edema, this condition
has been attributed to various factors which, alone or together,
trigger alterations that culminate in a dramatic and often ir-
reversible state. The main causes of pulmonary edema in-
clude a reduced colloid osmotic pressure caused by urinary
loss of proteins, inadequate infusion of crystalloids, blood loss
during delivery, and increased capillary permeability due to
endothelial damage associated or not with renal and cardiac
insufficiency.20 Another important factor is systolic dysfunc-
tion or impaired myocardial contraction resulting from hyper-
trophy of the left ventricle in patients with chronic hyper-
tension. The ventricular wall is thick and rigid and requires
a high filling pressure, a fact that predisposes pregnant
women to pulmonary edema when they retain excess sodium
and water during the final phase of gestation or in the case
of iatrogenic fluid overload.21
Coagulation disorders and HELLP syndrome, identified
in 16.2% of the present cases, are disorders in the preg-
nancy of PE/E and may occur in severe cases or when preg-
nant patients with arterial hypertension are managed con-
servatively. Mortality due to these disorders in pregnancy
is attributed to a late diagnosis or to a delay in the institu-
tion of appropriate therapeutic measures such as blood pres-
sure reduction. The main coagulopathies resulting from in-
creased blood pressure are premature detachment of the pla-
centa, HELLP syndrome, and liver rupture. In the present
study, HELLP syndrome was the leading cause, correspond-
ing to 52.2% of all coagulation disorders, in contrast to the
United States where premature detachment of the placenta
occupies the first place.10,22
In conclusion, analysis of the 142 cases of maternal
death due to hypertensive disorders in pregnancy showed
that the care provided to hypertensive pregnant women is
not adequate. There is a lack of previous preparation for
women with systemic arterial hypertension who wish to be-
come pregnant, adequate prenatal care coverage for women
with a history of some disease or for those who develop a
condition during pregnancy, and adequate guidance or pro-
cedures and medications to be adopted. This fact is con-
firmed by the finding that 13 pregnant women and four pu-
erperae arrived at the hospital in cardiorespiratory arrest.
In fact, as long as the government does not improve the
socioeconomic conditions of the population and does not
create units clearly and directly affiliated with tertiary care
hospitals providing differentiated care for risk pregnancies,
pregnant patients will arrive at the emergency room of hos-
pitals in even more descompensated and difficult-to-con-
trol conditions. It is of fundamental importance to stand-
ardize management and protocols for risk pregnancies based
on scientific evidence, and to provide specific medications
with a higher resolution power. The importance of a fam-
ily planning system adapted to the needs of this popula-
tion of hypertensive and older women, including adequate
procedures for each case, should be emphasized. Stress,
which is generally present in women with an undesired
pregnancy, has been indicated as one of the main causes
contributing to preeclampsia and its consequences.23
Finally, as long as no worthy basic care service is pro-
vided to the Brazilian population that includes well-struc-
tured family planning, quality and differentiated care for
pregnant women with arterial hypertension, and profession-
als qualified to diagnosis and appropriately treat obstetric dis-
orders in pregnancy, lives will be placed unnecessarily at risk.
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RESUMO
Vega CEP, Kahhale S, Zugaib M. A mortalidade materna
devido a hipertensão arterial na cidade de São Paulo (1995-
1999). Clinics. 2007;62(6):679-84.
OBJETIVO: Descrever o perfil dos casos de morte materna
decorrente de complicações da hipertensão arterial e propor
medidas para sua redução.
MÉTODOS: De 1995 a 1999 o Comitê de Mortalidade
Materna da Cidade de São Paulo identificou 609 casos de
morte materna obstétrica, com uma subnotificação de 52,2%
e um CMM=56,7/100.000 Nascidos Vivos. A hipertensão
arterial foi a principal causa de óbito materno,
correspondendo a 142 (23,3%) casos.
RESULTADOS: Ocorreram 95 (66,9%) de óbitos no
puerpério e 34 (23,9%) durante a gestação. Em 13 (9,2%)
casos não se teve referência ao momento do óbito. Houve
relato de crises convulsivas em 41 casos com a utilização
de sulfato de magnésio em quatro deles. As principais
causas determinantes do óbito foram: o acidente vascular
cerebral (44,4%), o edema agudo de pulmão (24,6%) e as
coagulopatias (14,1%). A cesárea foi realizada em 85
(59,9%) casos e o parto vaginal em 15 (16,0%). Em 28
(19,7%) casos não foi realizada nenhuma conduta para
interromper a gravidez e em 14 (9,8%) não se obteve relato
do procedimento.
CONCLUSÃO: As complicações da hipertensão arterial no
ciclo gravídico-puerperal determinam altos índices de
mortalidade materna na cidade de São Paulo. A realização
de um pré-natal de qualidade e o atendimento apropriado
da gestante hipertensa no parto e no pós-parto são medidas
de fundamental importância para um melhor controle desse
evento, sendo primordial para a redução dessas ocorrências.
UNITERMOS: Mortalidade materna. Hipertensão arterial.
Gestação de risco. Hipertensão arterial crônica. Pré-
eclâmpsia/eclâmpsia. Sulfato de magnésio.
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